ID

34272

Descripción

Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets; ODM derived from: https://clinicaltrials.gov/show/NCT01510522

Link

https://clinicaltrials.gov/show/NCT01510522

Palabras clave

  1. 16/1/19 16/1/19 -
  2. 14/5/19 14/5/19 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

16 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes Mellitus Type 2 NCT01510522

Eligibility Diabetes Mellitus Type 2 NCT01510522

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
diabetes mellitus type 2 diagnosed (baseline glycemia > 7,0 mmol/l (126 mg/dl) or overload glycemia > 11,0 mmol/l (198 mg/dl)
Descripción

ID.1

Tipo de datos

boolean

on treatment with metformin tablets
Descripción

ID.2

Tipo de datos

boolean

patients with at least 2 treated co-morbidities
Descripción

ID.3

Tipo de datos

boolean

established dose of metformin > 1.700 mg/day
Descripción

ID.4

Tipo de datos

boolean

age > 18 years old
Descripción

ID.5

Tipo de datos

boolean

given informed consent
Descripción

ID.6

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients not able to take medication orally
Descripción

ID.7

Tipo de datos

boolean

according to summary of product characteristics (smpc)
Descripción

ID.8

Tipo de datos

boolean

participating in another clinical trial 30 days prior to randomization
Descripción

ID.9

Tipo de datos

boolean

any other illness or medical or psychiatric condition, severe and uncontrolled that could interfere in the patient's participation or in the assessment of the study results
Descripción

ID.10

Tipo de datos

boolean

Similar models

Eligibility Diabetes Mellitus Type 2 NCT01510522

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
diabetes mellitus type 2 diagnosed (baseline glycemia > 7,0 mmol/l (126 mg/dl) or overload glycemia > 11,0 mmol/l (198 mg/dl)
boolean
ID.2
Item
on treatment with metformin tablets
boolean
ID.3
Item
patients with at least 2 treated co-morbidities
boolean
ID.4
Item
established dose of metformin > 1.700 mg/day
boolean
ID.5
Item
age > 18 years old
boolean
ID.6
Item
given informed consent
boolean
Item Group
C0680251 (UMLS CUI)
ID.7
Item
patients not able to take medication orally
boolean
ID.8
Item
according to summary of product characteristics (smpc)
boolean
ID.9
Item
participating in another clinical trial 30 days prior to randomization
boolean
ID.10
Item
any other illness or medical or psychiatric condition, severe and uncontrolled that could interfere in the patient's participation or in the assessment of the study results
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial